IBDEI0J6 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8627,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,8628,0)
 ;;=D61.82^^39^401^180
 ;;^UTILITY(U,$J,358.3,8628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8628,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,8628,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,8628,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,8629,0)
 ;;=D47.9^^39^401^181
 ;;^UTILITY(U,$J,358.3,8629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8629,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,8629,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,8629,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,8630,0)
 ;;=D53.9^^39^401^185
 ;;^UTILITY(U,$J,358.3,8630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8630,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,8630,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,8630,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,8631,0)
 ;;=D47.4^^39^401^186
 ;;^UTILITY(U,$J,358.3,8631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8631,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,8631,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,8631,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,8632,0)
 ;;=D51.3^^39^401^210
 ;;^UTILITY(U,$J,358.3,8632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8632,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,8632,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,8632,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,8633,0)
 ;;=D77.^^39^401^62
 ;;^UTILITY(U,$J,358.3,8633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8633,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,8633,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,8633,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,8634,0)
 ;;=D58.2^^39^401^88
 ;;^UTILITY(U,$J,358.3,8634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8634,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,8634,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,8634,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,8635,0)
 ;;=C88.8^^39^401^110
 ;;^UTILITY(U,$J,358.3,8635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8635,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,8635,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,8635,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,8636,0)
 ;;=D70.8^^39^401^183
 ;;^UTILITY(U,$J,358.3,8636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8636,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,8636,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,8636,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,8637,0)
 ;;=D59.4^^39^401^184
 ;;^UTILITY(U,$J,358.3,8637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8637,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,8637,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,8637,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,8638,0)
 ;;=D69.59^^39^401^190
 ;;^UTILITY(U,$J,358.3,8638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8638,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,8638,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,8638,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,8639,0)
 ;;=C22.7^^39^401^51
 ;;^UTILITY(U,$J,358.3,8639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8639,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,8639,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,8639,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,8640,0)
 ;;=D75.89^^39^401^61
 ;;^UTILITY(U,$J,358.3,8640,1,0)
 ;;=^358.31IA^4^2
